Clinical data on Fluarix^®: an inactivated split seasonal influenza vaccine

References

• Crighton EJ, Moineddin R, Mamdani M, Upshur RE. Influenza and pneumonia hospitalizations in Ontario: a time-series analysis. Epidemiol. Infect.132, 1167–1174 (2004).
   PubMed Web of Science ®Google Scholar
• Shek LP, Lee BW. Epidemiology and seasonality of respiratory tract virus infections in the tropics. Paediatr. Respir. Rev.4, 105–111 (2003).
   PubMedGoogle Scholar
• Eickhoff TC, Sherman IL, Serfling RE. Observations on excess mortality associated with epidemic influenza. JAMA176, 776–782 (1961).
   PubMed Web of Science ®Google Scholar
• Thompson WW, Shay DK, Weintraub E et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA289, 179–186 (2003).
   PubMed Web of Science ®Google Scholar
• Falsey AR, Hennessey PA, Formica MA, Cosx C, Walsh EE. Respiratory syncytial virus infection in elderly and high risk adults. N. Engl. J. Med.352, 1749–1759 (2005).
   PubMed Web of Science ®Google Scholar
• Lui KJ, Kendal AP. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985. Am. J. Public Health77, 712–716 (1987).
   PubMed Web of Science ®Google Scholar
• Choi K, Thacker SB. Mortality during influenza epidemics in the United States, 1967–1978. Am. J. Public Health72, 1280–1283 (1982).
   PubMed Web of Science ®Google Scholar
• Alling DW, Blackwelder WC, Stuart-Harris CH. A study of excess mortality during influenza epidemics in the United States, 1968–1976. Am. J. Epidemiol.113, 30–43 (1981).
   Google Scholar
• Simonsen L, Clarke MJ, Williamson D, Stroup DF, Arden NH, Schonberger LB. The impact of influenza epidemics on mortality: introducing a severity index. Am. J. Public Health87, 1944–1950 (1997).
   PubMed Web of Science ®Google Scholar
• Bhat N, Wright JG, Broder KR et al. Influenza-associated deaths among children in the United States, 2003–2004. N. Engl. J. Med.353, 2559–2567 (2005).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Clarke MJ, Schonberger LB, Arden NH, Cox NJ, Fukuda K. Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. J. Infect. Dis.178, 53–60 (1998).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Reichert TA, Viboud C, Blackwater WC, Taylro RJ, Miller MA. Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch. Int. Med.165, 265–72 (2005).
   PubMed Web of Science ®Google Scholar
• Wright PF, Ross KB, Thompson J, Karzon DT. Influenza A infections in young children: primary natural infection and protective efficacy of live vaccine-induced or naturally immunity. N. Engl. J. Med.296, 829–834 (1977).
   PubMed Web of Science ®Google Scholar
• Glezen WP, Couch RB. Interpandemic influenza in the Houston area, 1974–76. N. Engl. J. Med.298, 587–592 (1978).
   PubMed Web of Science ®Google Scholar
• Neuzil KM, Mellen BG, Wright PF, Mitchel EF, Griffin MR. The effects of influenza on hospitalizations, outpatient visits and courses of antibiotics in children. N. Engl. J. Med.342, 225–231 (2000).
   PubMed Web of Science ®Google Scholar
• Izurieta HS, Thompson WW, Kramarz P et al. Influenza and the rates of hospitalization for respiratory disease among infants and young children. N. Engl. J. Med.342, 232–239 (2000).
   PubMed Web of Science ®Google Scholar
• Molinari NA, Ortega-Sanchez IR, Messonier ML et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine25, 5086–5096 (2007).
   PubMed Web of Science ®Google Scholar
• Demicheli V, Rivetti D, Deeks JJ, Jefferson TO. Vaccines for preventing influenza in healthy adults. Cochrane Database Syst. Rev.2, CD001269 (2007).
   Google Scholar
• Rothberg MB, Rose DN. Vaccination versus treatment of influenza in working adults: a cost effectiveness analysis. Am. J. Med.118, 68–77 (2005).
   PubMed Web of Science ®Google Scholar
• Bridges CB, Thompson WW, Meltzer MI et al. Effectiveness and cost–benefit of influenza vaccination of healthy working adults – a randomized controlled trial. JAMA284, 1655–1663 (2000).
   PubMed Web of Science ®Google Scholar
• Belshe RB, Nichol KL, Black SB et al. Safety, efficacy, and effectiveness of live, attenuated, cold-adapted influenza vaccine in an indicated population aged 5–49 years. Clin. Infect. Dis.39, 920–927 (2004).
   PubMed Web of Science ®Google Scholar
• Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA272, 1661–1665 (1994).
   PubMed Web of Science ®Google Scholar
• Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, Demicheli V. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet366, 1165–1174 (2005).
   PubMed Web of Science ®Google Scholar
• Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E. Effectiveness of influenza vaccine in the community-dwelling elderly. N. Engl. J. Med.357, 1373–1381 (2007).
   PubMed Web of Science ®Google Scholar
• Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect. Dis.7, 658–666 (2007).
   PubMed Web of Science ®Google Scholar
• Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS. Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int. J. Epidemiol.35, 337–344 (2006).
   PubMed Web of Science ®Google Scholar
• Jefferson T, Smith S, Demicheli V, Hamden A, Rivetti A, Di Pietrantonj C. Assessment of the efficacy and effectivenss of influenza vaccines in healthy children: systematic review. Lancet365, 773–780 (2005).
   PubMed Web of Science ®Google Scholar
• Monto AS, Davenport FM, Napier A, Francis T Jr. Effect of vaccination of a school-age population upon the course of an A2/Hong Kong influenza epidemic. Bull. World Health Organ.41, 537–542 (1969).
   PubMed Web of Science ®Google Scholar
• Piedra PA, Gaglani MJ, Kozinetz CA et al. Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children. Vaccine23, 1540–1548 (2005).
   PubMed Web of Science ®Google Scholar
• Hurwitz ES, Haber M, Chang A et al. Effectiveness of influenza vaccination of day care children in reducing influenza-related morbidity among household contacts. JAMA284, 1677–1682 (2000).
   PubMed Web of Science ®Google Scholar
• Glezen WP. Herd protection against influenza. J. Clin. Virol.37, 237–243 (2006).
   PubMed Web of Science ®Google Scholar
• Fiore AE, Shay DK, Haber P et al. Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2007. MMWR Recomm. Rep.56, 1–54 (2007).
   PubMedGoogle Scholar
• Treanor JJ, Campbell JD, Brady RC et al. Rapid licensure of a new, inactivated influenza vaccine in the United States. Hum. Vaccin.1, 239–244 (2005).
   PubMed Web of Science ®Google Scholar
• Hobson D, Curry RL, Beare AS, Ward-Gardner A. The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. J. Hyg.70, 767–777 (1972).
   PubMedGoogle Scholar
• Treanor J, Wright PF. Immune correlates of protection against influenza in the human challenge model. Dev. Biol.115, 97–104 (2003).
   Google Scholar
• Hehme NW, Kunzel W, Petschke F et al. Ten years experience with the trivalent split-influenza vaccine, Fluarix. Clin. Drug Invest.22, 751–769 (2002).
   Web of Science ®Google Scholar
• Beran J, Prymula R, Chlíbek R et al. Evaluation of reactogenicity and immunogenicity of two influenza vaccines (vaxigrip and fluarix) in the season 1996–1997. Cent. Eur. J. Public Health6, 269–273 (1998).
   PubMed Web of Science ®Google Scholar
• Committee for Proprietary Medicinal Products (CPMP). Note for Guidance on Harmonization of Requirements for Influenza Vaccines CPMP/BWP/214/96. The European Agency for the Evaluation of Medicinal Products, London, UK (1997).
   Google Scholar
• Kanra G, Marchisio P, Feiterna-Sperling C et al. Comparison of immunogenicity and tolerability of a virosome-adjuvanted and a split influenza vaccine in children. Pediatr. Infect. Dis. J.23, 300–306 (2004).
   PubMed Web of Science ®Google Scholar
• Kanakoudi-Tsakalidou F, Trachana M, Pratsidou-Gertsi P, Tsitsami E, Kyriazopoulou-Dalaina V. Influenza vaccination in children with chronic rheumatic diseases and long-term immunosuppressive therapy. Clin. Exp. Rheumatol.19, 589–594 (2001).
   PubMed Web of Science ®Google Scholar
• Goodwin K, Viboud C, Simonsen L. Antibody response to influenza vaccination in the elderly: a quantitative review. Vaccine24, 1159–1169 (2006).
   PubMed Web of Science ®Google Scholar
• Webster RG. Immunity to influenza in the elderly. Vaccine18, 1686–1689 (2000).
   PubMed Web of Science ®Google Scholar
• Targonski PV, Jacobson RM, Poland GA. Immunosenescence: role and measurement in influenza vaccine response among the elderly. Vaccine25, 3066–3069 (2007).
   PubMed Web of Science ®Google Scholar
• Ruf BR, Colberg K, Frick M, Preusche A. Open, randomized study to compare the immunogenicity and reactogenicity of an influenza split vaccine with an MF59-adjuvanted subunit vaccine and a virosome-based subunit vaccine in elderly. Infection32, 191–198 (2004).
   PubMed Web of Science ®Google Scholar
• Van Hoecke C, Prikazsky V, Utö I, Menschikowski C. Immunogenicity of an inactivated split influenza vaccine in institutionalized elderly patients. Gerontology42, 190–198 (1996).
   PubMed Web of Science ®Google Scholar
• Brydak LB, Calbecka M. Immunogenicity of influenza vaccine in patients with hemato–oncological disorders. Leuk. Lymphoma32, 369–374 (1999).
   PubMed Web of Science ®Google Scholar
• Burbach G, Bienzle U, Stark K et al. Influenza vaccination in liver transplant recipients. Transplantation67, 753–755 (1999).
   PubMed Web of Science ®Google Scholar
• Brydak LB, Machala M, Laguna P, Rokicka-Milewska R. Antibody response to influenza vaccination in splenectomized patients in Poland. J. Clin. Immunol.24, 225–236 (2004).
   PubMed Web of Science ®Google Scholar
• Cox MM. Progress on baculovirus-derived influenza vaccines. Curr. Opin. Mol. Therap.10, 56–61 (2008).
   PubMedGoogle Scholar
• Tosh PK, Poland GA. Emerging vaccines for influenza. Expert Opin. Emerg. Drugs13, 21–40 (2008).
   PubMed Web of Science ®Google Scholar
• Ernst WA, Kim HJ, Tumpey TM et al. Protection against H1, H5, H6 and H9 influenza A infection with liposomal matrix 2 epitope vaccines. Vaccine24, 5158–5168 (2006).
   PubMed Web of Science ®Google Scholar
• Epstein CL, Kong WP, Misplon JA et al. Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. Vaccine23, 5404–5410 (2005).
   PubMed Web of Science ®Google Scholar
• Keitel WA, Atmar RL, Cate TR et al. Safety of high doses of influenza vaccine and effect on antibody responses in elderly persons. Arch. Intern. Med.166, 1121–1127 (2006).
   PubMed Web of Science ®Google Scholar